Abstract
THE effects of ribonuclease on ascites tumours have been described recently1. The present communication gives preliminary results obtained on two solid tumours, namely, the spontaneous mammary tumour in C3H or C + mice and the Crocker 180 sarcoma in C + mice.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Ledoux, L., and Baltus, E., Experientia, 10, 500 (1954). Ledoux, L., Nature, 175, 258 (1955).
Ledoux, L., and Brachet, J., Biochim. et Biophys. Acta, 16, 289 (1955).
Brachet, J., Nature, 174, 876 (1954).
Ledoux, L., Biochim. et Biophys. Acta, 14, 267 (1954).
Haddow, A., J. Path. Bact., 68, 553 (1938).
Woolley, D. W., and Schaffner, G., Cancer Research, 14, 802 (1954).
Haddow, A., et al., Brit. Emp. Cancer Camp. Ann. Rep., 31, 35 (1953).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
LEDOUX, L. Action of Ribonuclease on Two Solid Tumours in vivo . Nature 176, 36–37 (1955). https://doi.org/10.1038/176036a0
Issue Date:
DOI: https://doi.org/10.1038/176036a0
- Springer Nature Limited
This article is cited by
-
Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways
Journal of Experimental & Clinical Cancer Research (2016)
-
Mechanisms of enhanced tumoricidal efficacy of multiple small dosages of ranpirnase, the novel cytotoxic ribonuclease, on lung cancer
Cancer Chemotherapy and Pharmacology (2008)
-
Structures of proteins of biomedical interest from the Center for Eukaryotic Structural Genomics
Journal of Structural and Functional Genomics (2007)
-
Natural and engineered ribonucleases as potential cancer therapeutics
Biotechnology Letters (2006)
-
Search for new antitumor agents among biopolymers and their synthetic analogs
Pharmaceutical Chemistry Journal (1976)